FIELD: biotechnology.
SUBSTANCE: invention relates to production of non-toxic mutant forms of Vibrio cholera Cholix gene (ntCholix), and can be used in medicine. Variant of Cholix is produced, which is truncated at amino acid A386 (Cholix386) or with a removable residue Glu581. Obtained non-toxic variant of Cholix is linked with therapeutic load, which can be a macromolecule, small molecule, siRNA, PNA miRNA, DNA, plasmid and an antisense molecule.
EFFECT: invention provides delivery of therapeutic load through polarised epithelial cells, including intestine, in direction from apical to basolateral surface of monolayers of cells without injections.
11 cl, 2 dwg, 3 ex
Authors
Dates
2016-08-10—Published
2011-09-15—Filed